Connection
William Janssen to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications William Janssen has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
Connection Strength |
|
 |
|
 |
|
0.076 |
|
|
|
-
Janssen W, Ghofrani HA, Weissmann N, Grimminger F, Schermuly RT. [Update: Preclinical developments for the treatment of pulmonary arterial hypertension]. Dtsch Med Wochenschr. 2009 Aug; 134 Suppl 5:S157-9.
Score: 0.063
-
Morimoto K, Janssen WJ, Fessler MB, McPhillips KA, Borges VM, Bowler RP, Xiao YQ, Kench JA, Henson PM, Vandivier RW. Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol. 2006 Jun 15; 176(12):7657-65.
Score: 0.013